Phase I/II trial of preoperative capecitabine with concurrent radiation therapy for locally advanced rectal cancer in a Japanese population.
Not Applicable
Recruiting
- Conditions
- rectal cancer
- Registration Number
- JPRN-UMIN000003701
- Lead Sponsor
- Wakayama Medical University, Second Department of Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
Not provided
Exclusion Criteria
1. Stage IV rectal cancer, rectal cancer with bowel obstruction. 2. Pregnancy. 3. Lactation. 4. Pregnancy attempy. 5. Infectious diseases. 6. Use of immunosuppressive drug and steroid. 7. Double cancer. 8. Injury and wound. 9. Paralytic ileus and interstitial pneumonia. 10. Doctor's exclusion decision.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method